Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Journal of Human Hypertension|June 1, 1987
Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertensionD R Singer, N D Markandu, A C Shore, et al.Annales De Medecine Interne|January 1, 1986
Cryoglobulinaemia: clinical features and response to treatmentD R Singer, M C Venning, C M Lockwood, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertensionD R Singer, N D Markandu, L Furnival, et al.Cardiovascular Research|August 1, 1993
Studies of cardiopulmonary bypass in children: implications for the regulation of brain natriuretic peptideA Ationu, D R Singer, A Smith, et al.Hypertension (Dallas, Tex. : 1979)|April 16, 1999
Structural skin capillary rarefaction in essential hypertensionT F Antonios, D R Singer, N D Markandu, et al.European Journal of Internal Medicine|November 17, 2001
Coronary heart disease in the statin and aspirin era: are results of clinical trials being put into practice?C G Missouris, R G Kalaitzidis, N Parchure, et al.Journal of Human Hypertension|April 1, 1994
Double-blind crossover study of once daily nifedipine coat core in essential hypertensionC G Missouris, F P Cappuccio, N D Markandu, et al.Hypertension (Dallas, Tex. : 1979)|October 16, 1999
Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormalityT F Antonios, D R Singer, N D Markandu, et al.European Heart Journal|June 29, 2001
Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriogramsT F Antonios, J C Kaski, K M Hasan, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|October 31, 1990
Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating formM G Buckley, G A Sagnella, N D Markandu, et al.Pageof 8